Furthermore, LAG3 expression by engineered tumor cells efficiently promotes and facilities activation, intratumoral recruitment, and Th1 commitment of APCs, which results in a large intratumoral influx of specific and non-specific reactive cells, as well as the release of immunoregulatory and cytotoxic mediators (69). Here, LAG3 is linked to neoplasm.